**For the attention of medical professionals!** Changes have been made to the Instruction for the medical use of the drug **Aminocapronic acid 5% infusion solution**, manufactured by **JSC "Kraspharma"**, reg. number **RN002281/01**.
01.02.2016
**For the attention of medical professionals!** Changes have been made to the Instruction for the medical use of the drug **Aminocapronic acid 5% infusion solution**, manufactured by **JSC "Kraspharma"**, reg. number **RN002281/01**.
On January 20, 2016, the Ministry of Health of the Russian Federation approved amendments to the Instruction for the medical use of the drug **Aminocapronic acid 5% infusion solution**, manufactured by **JSC "Kraspharma"**, reg. number **RN002281/01**.
The changes were made to the following sections of the Instruction for use:
According to the revised Instruction, effective from January 20, 2016, the restrictions on the use of **Aminocapronic acid 5% infusion solution** have been reviewed, and the specifics of its use in special patient categories have been clarified.
A new dosage form of the drug has been registered – in polymer bags.
The changes were made to the following sections of the Instruction for use:
- Composition
- Contraindications
- Precautions
- Special instructions
- Dosage form
According to the revised Instruction, effective from January 20, 2016, the restrictions on the use of **Aminocapronic acid 5% infusion solution** have been reviewed, and the specifics of its use in special patient categories have been clarified.
A new dosage form of the drug has been registered – in polymer bags.
